Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and efficacy of Seroquel [quetiapine] in first episode schizophrenia.

Trial Profile

Safety and efficacy of Seroquel [quetiapine] in first episode schizophrenia.

Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2009

At a glance

  • Drugs Quetiapine; Risperidone
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Acronyms Esquire
  • Sponsors AstraZeneca
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 16 Jun 2009 Trial phase changed from III to IV as reported by ClinicalTrials.gov.
    • 17 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top